PPARγ inhibition promotes osteogenic differentiation of bone marrow mesenchymal stem cells and fracture healing
Authors:
- 15 April 2024
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 125 (6)
Abstract
This study aimed to explore the effects of peroxisome proliferator‐activated receptor γ (PPARγ) inhibition on fracture healing of nonunion and the underlying mechanisms. Bone marrow mesenchymal stem cells (BMSCs) were treated with PPARγ antagonist GW9662 (5 μM, 10 μM). Alkaline phosphatase (ALP) staining and Alizarin Red S was used to assess early stage of osteogenesis and osteogenic differentiation. GW9662 (1 mg/kg/day) were administered intraperitoneally into the rats with bone fracture. Bone healing processes in the rat femur fracture model were recorded and assessed by radiographic methods on Weeks 8, 14, and 20 postoperation. Osteogenesis and angiogenesis at the fracture sites were evaluated by radiographic and histological methods on postoperative Week 20. GW9662 treatment increased ALP activity and Alp mRNA expression in rat BMSCs. Moreover, GW9662 administration increased matrix mineralization and mRNA and protein levels of Bmp2 and Runx2 in the BMSCs. In addition, GW9662 treatment improved radiographic score in the fracture rats and increased osteogenesis‐related proteins, including type I collagen, osteopontin, and osteoglycin, in the bone tissues of the fracture sites. In conclusion, PPARγ inhibition promotes osteogenic differentiation of rat BMSCs, as well as improves the fracture healing of rats through Bmp2/Runx2 signaling pathway in the rat model of bone fracture.Keywords
This publication has 31 references indexed in Scilit:
- DEPTOR exacerbates bone–fat imbalance in osteoporosis by transcriptionally modulating BMSC differentiationBiomedicine & Pharmacotherapy, 2022
- Geraniin promotes osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) via activating β-catenin: a comparative study between BMSCs from normal and osteoporotic ratsJournal of Natural Medicines, 2018
- Reciprocal Regulation of PPARγ and RUNX2 Activities in Marrow Mesenchymal Stem Cells: Fine Balance between p38 MAPK and Protein Phosphatase 5Current Molecular Biology Reports, 2017
- Gremlin2 Suppression Increases the BMP-2-Induced Osteogenesis of Human Bone Marrow-Derived Mesenchymal Stem Cells Via the BMP-2/Smad/Runx2 Signaling PathwayJournal of Cellular Biochemistry, 2016
- Biological Silicon Stimulates Collagen Type 1 and Osteocalcin Synthesis in Human Osteoblast-Like Cells Through the BMP-2/Smad/RUNX2 Signaling PathwayBiological Trace Element Research, 2016
- Bone fracture healing: Cell therapy in delayed unions and nonunionsBone, 2015
- Meta-Analysis Comparing Arthroplasty with Internal Fixation for Displaced Femoral Neck Fracture in the ElderlyJournal of Surgical Research, 2011
- Chondrogenic differentiation of bovine synovium: Bone morphogenetic proteins 2 and 7 and transforming growth factor β1 induce the formation of different types of cartilaginous tissueArthritis & Rheumatism, 2007
- Identification of novel Runx2 targets in osteoblasts: Cell type‐specific BMP‐dependent regulation of Tram2Journal of Cellular Biochemistry, 2007
- BMP‐2 promotes differentiation of osteoblasts and chondroblasts in Runx2‐deficient cell linesJournal of Cellular Physiology, 2007